Trademark: 79353355
Word
QUANTOOM
Status Date
Monday, February 19, 2024
Filing Date
Thursday, August 11, 2022
Published for Opposition
Tuesday, January 23, 2024
40 Custom manufacturing of biologics, namely, custom manufacturing of biologics using biological organisms in the manufacturing process; custom manufacturing of nucleic acids for clinical trials and for commercial supply by pharmaceutical compounders; custom manufacturing services in the field of biologics, pharmaceuticals, biopharmaceuticals, health care, cell culture and gene therapy and medical products, namely, custom manufacturing of biologic, pharmaceuticals, and biopharmaceuticals; treatment of pharmaceutical and chemical products and their components during the custom manufacture of pharmaceuticals, biopharmaceuticals and nucleic acids; providing advice related to the custom manufacture of pharmaceuticals and materials for clinical trials and for commercial supply; providing information in the field of the custom manufacture of nucleic acids for clinical trials and for commercial supply
7 Industrial machines for the production of nucleic acids; parts of industrial machines for the production of nucleic acids, namely, single use trays of reactor tubes
42 Scientific research and technological consultancy services in the field of analysis and production of nucleic acids; research and development of nucleic acid generation platforms; scientific research and development applied in particular in the biological, technological and biotechnological fields, namely, design of processes, equipment, disposables and consumables for producing nucleic acids; scientific research and technological development and advice services, namely, custom design, sequencing in the nature of testing, analysis and evaluation and development of nucleic acid generation platforms; engineering services; scientific research and technological consultancy on process development relating to manufacture of nucleic acids; industrial process development for manufacturing of medical preparations; engineering services and scientific research and technological consultancy, all on production units for DNA and RNA synthesis; design of tools for the production of biologics; advisory services relating to industrial engineering in the field of manufacturing of biologics; rental of laboratory apparatus and instruments; technological development services in the nature of product development, technology advice and information services in the nature of providing technology information in the field of pharmaceuticals and engineering consultation services in the field of the production of nucleic acids
The mark consists of the word "QUANTOOM" stylized. The letter "Q" is in upper case and the letters "UANT" and "M" are in lower case. The letters "QUANT" and "M" are in black. The two letters "OO" are replaced by two intertwined squares in two shades of orange. The second square on the right is open and the edges are open towards the direction of letter "M". The color white shown inside the squares represents background and is not claimed as a feature of the mark.
The colors orange and black are claimed as a feature of the mark.
Apr 8, 2024
Notification Of Possible Opposition - Processed By Ib
Mar 20, 2024
Notification Of Possible Opposition Sent To Ib
Mar 20, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Feb 19, 2024
Extension Of Time To Oppose Received
Jan 23, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 23, 2024
Published For Opposition
Jan 22, 2024
Notification Processed By Ib
Jan 3, 2024
Notification Of Possible Opposition Sent To Ib
Jan 3, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 3, 2024
Notification Of Notice Of Publication E-Mailed
Dec 21, 2023
Teas Change Of Correspondence Received
Dec 21, 2023
Teas Change Of Domestic Representatives Address
Dec 21, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 21, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 21, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 21, 2023
Teas Change Of Owner Address Received
Dec 17, 2023
Approved For Pub - Principal Register
Dec 15, 2023
Teas/Email Correspondence Entered
Dec 14, 2023
Correspondence Received In Law Office
Dec 14, 2023
Teas Response To Office Action Received
Aug 1, 2023
Refusal Processed By Ib
Jul 10, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jul 10, 2023
Refusal Processed By Mpu
Jun 3, 2023
New Representative At Ib Received
Jun 3, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Jun 2, 2023
Non-Final Action Written
May 31, 2023
Assigned To Examiner
Oct 25, 2022
Application Filing Receipt Mailed
Oct 21, 2022
New Application Office Supplied Data Entered
Oct 20, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
